HQH News and Press, Tekla Healthcare Investors From 02/18/20

Tekla Healthcare Investors (NYSE: HQH ) declares $0.47/share stock distribution , 14.6% increase from prior distribution of $0.41. Payable March 31; for shareholders of record Feb. 28; ex-div Feb. 27. See HQH Dividend Scorecard, Yield Chart, & Dividend Growth. More news on: Te...

Despite the coronavirus concerns that have hit commodity markets and, in turn, energy and basic materials stocks, U.S. tech stocks have posted strong returns to start the year. This continues their impressive streak from 2019. But are the current tech valuations sustainable? In a recent mark...

Co-produced by Stanford Chemist It's no secret that broadly speaking the market is looking a bit frothy as of late, as we continue to charge higher into 2020. This was even on the back of a potential war scare . I'm sure this won't be the last we hear of the U.S.-Iran conflict for the y...

By Vinay Thapar and Frank Caruso US healthcare is always a political hot potato, and volatility is expected to rise as the November elections approach. But investors can find good opportunities in the sector in companies with strong long-term business drivers that are relatively immune to ...

By Michelle Borré, CFA, Head of Fundamental Alternative Strategies , and Brian Giesen, CFA, Intermediate Research Analyst Restrictions on the pricing of drugs delivered in doctors' offices and hospitals could have significant investment implications. The Trump Administration is...

The stock market has been making new all-time highs for the past several months on the back of low-interest rates and trade deal optimism. The rally that started in the fourth quarter of last year continued in the new year. However, the rally was briefly paused in the last week due to the he...

Co-produced by Stanford Chemist . 2019 had been quite the year. We experienced a tremendous performance of almost 30% ( final return clocked in at 28.8%, with dividend reinvestment this was 31.49%). This can be compared to the S&P 500's 8% average annual returns. Before the index sta...

The presidential election year has begun, and the rhetoric around healthcare policy is likely to get louder as campaigning heats up. Tony DeSpirito talks with Portfolio Manager Erin Xie about the implications for health care stocks. In a year-end poll of our Fundamental Active Equity inves...

The "8% Income Portfolio" continues to perform well during good times and bad. Currently, it provides a 10.80% yield on the cost basis and a 7.02% yield on the current value of the portfolio. During the year 2019, the portfolio has returned more than 30% (26.5% after including cash reserve) ...

A good run The portfolio was up 6.06% in Q4 and 26.79% for 2019. The four-year gain has been 62.40%. We've had several good runs since I began investing in 1982. At some point, we'll have a bear market. Don't get complacent. During 2019, we began taking monthly distributions from my IRA. I...